JAFRAL Supports Slovenia’s First Cancer Gene Therapy Trial

We are proud to be part of the SmartGene.Si consortium, which has launched the first cancer gene therapy trial in Slovenia at the Institute of Oncology Ljubljana.

The therapeutic, its preparation, and the entire production platform are the result of Slovenian expertise and collaboration within the project consortium. JAFRAL contributed by producing the clinical trial material (pDNA).

Other consortium partners include the Institute of Oncology Ljubljana, COBIK, IskraPio, and the Faculty of Electrical Engineering, University of Ljubljana.

‍